Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06811545 · ClinicalTrials.gov registry record · NA
Evaluating the Effects of an Electrical Stimulator on Improving the Walking Ability of Children With Cerebral Palsy
A NA study, sponsored by University of Nebraska.
- Not yet
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT06811545: Clinical Trial NA study, sponsored by University of Nebraska.
NCT06811545 is a NA study that has not yet begun recruiting, run by University of Nebraska. The registered enrollment target is 65 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06811545, a NA study, has not yet begun recruiting, sponsored by University of Nebraska.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
The goal of this study is to see if gentle electrical stimulation can help children with cerebral palsy (CP) walk more easily. This stimulation, called neuromuscular electrical stimulation (NMES), sends small pulses to muscles to help them activate. Researchers will test different ways of using NMES to find out which method works best. Participants will walk on a treadmill at a comfortable speed while NMES is applied to leg muscles. The study will compare different stimulation settings to see which one helps the most.
Primary Outcome
Gait Variable Index (GDI) is an index of gait pathology based on 15 different kinematic measures (bilaterally) or nine unilaterally. The GDI score ranges from 0 to 100 where 100 represents atypically developing's (TD) normal GDI score.
Interventions
- DEVICE Neuromuscular Electrical Stimulation (NMES)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2026-05 |
| Est. Completion | 2029-07 |
| Phase | NA |
What is known before NCT06811545 opens enrollment
NCT06811545 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Neuromuscular Electrical Stimulation (NMES) is the first listed.
NCT06811545 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06811545 about?
NCT06811545 is a clinical study titled "Evaluating the Effects of an Electrical Stimulator on Improving the Walking Ability of Children With Cerebral Palsy". The goal of this study is to see if gentle electrical stimulation can help children with cerebral palsy (CP) walk more easily. This stimulation, called neuromuscular electrical stimulation (NMES), sends small pulses to muscles to help them activate. Researchers will test different ways of using NMES...
What is the current status of trial NCT06811545?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 65 participants. The study started on 2026-05. Estimated completion is 2029-07.
What interventions are being tested in trial NCT06811545?
The interventions under investigation include: Neuromuscular Electrical Stimulation (NMES) (DEVICE).
Who is sponsoring clinical trial NCT06811545?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06811545's enrollment target sits among peer trials
65 1144th of 2000 higher than 854 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia